Johnson & Johnson's COVID-19 Vaccine is Back After Pause to Investigate Blood Clots / VIDEO
*It’s like this. More than a week after being paused by regulators, use of Johnson & Johnson‘s COVID-19 vaccine will be restarted after being investigated due to reports that it caused users to develop blood clots as aside effect. US health regulators will add a warning to the vaccine about the risk of unusual blood clots in women under 50. Still, the shots remain a valuable tool to stop the pandemic, and US health authorities said the benefits of the vaccines in preventing COVID-19 outweigh the risks. MORE NEWS ON EURWEB: Here’s MORE via Insider: The US paused its rollout of the vacc...
Source: eurweb.com